caption
stringlengths 6
2.51k
|
|---|
The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, barth syndrome, and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, cholesterol translocation that impacts aging and tangier disease. |
The molecule is a proton trap for oxidative phosphorylation and a apoptosis that impacts aging, tangier disease, and non-alcoholic fatty liver disease. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts barth syndrome and diabetic heart disease. |
The molecule is a energy storage and a nutrient that impacts cardiovascular disease, metabolic syndrome, obesity, and cancer. The molecule is a energy source and thyroxine treatment, and it impacts pancreatitis. The molecule is a fat storage, a inflammatory, and a membrane stabilizer, and it impacts atherosclerosis. |
The molecule is a stabilizing mitochondrial structure and a apoptosis that impacts barth syndrome, diabetic heart disease, and aging. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and tangier disease. |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts diabetic heart disease, tangier disease, and aging. The molecule is a proton trap for oxidative phosphorylation, stabilizing mitochondrial structure, cholesterol translocation that impacts non-alcoholic fatty liver disease and barth syndrome. |
It has an effect on lightening. |
The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts diabetic heart disease, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, cholesterol translocation that impacts tangier disease and aging. |
The molecule is a stabilizing cytochrome oxidase, apoptosis, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts tangier disease, aging, and barth syndrome. |
The molecule is a hdm2 inhibitor and is cancer treatment. |
The molecule is apricot, fruity, ethereal, and banana. The molecule is a flavoring agent, musty, sweet, and oily. |
Ethylene dichloride decomposes slowly becoming acidic and darkening in color. The molecule has both a Sweet taste and a Pleasant odor. |
The molecule is a energy source, inflammatory, membrane stabilizer that impacts metabolic syndrome, obesity, and atherosclerosis. The molecule is a energy storage that affects cancer by impacting pancreatitis. The molecule is a nutrient, a fat storage, and a thyroxine treatment, and it impacts cardiovascular disease. |
The molecule is photoresist. |
The molecule is a apoptosis, cholesterol translocation, proton trap for oxidative phosphorylation that impacts barth syndrome and diabetic heart disease. The molecule is a stabilizing mitochondrial structure and a stabilizing cytochrome oxidase that impacts aging, tangier disease, and non-alcoholic fatty liver disease. |
The molecule is cancer treatment and anti apoptotic. |
The molecule is a btk inhibitor. |
The molecule is a thyroxine treatment, energy storage, fat storage, inflammatory that impacts atherosclerosis and obesity. The molecule is a energy source and membrane stabilizer, and it impacts metabolic syndrome. The molecule is a nutrient that affects cancer by impacting both cardiovascular disease and pancreatitis. |
The molecule is a acc inhibitor and a cancer treatment, belonging to the metabolic syndrome treatment class of molecules. |
The molecule is a nutrient that affects breast cancer by impacting cervical cancer, atherosclerosis, and ulcerative colitis. |
The molecule is a membrane stabilizer and fat storage, belonging to the thyroxine treatment class of molecules, with effects on cancer and impacts on both obesity and metabolic syndrome. The molecule is a inflammatory, a energy source, and a energy storage. The molecule is a nutrient that impacts atherosclerosis, pancreatitis, and cardiovascular disease. |
The molecule is a cholesterol translocation that impacts diabetic heart disease, tangier disease, aging, and barth syndrome. The molecule is a apoptosis, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease. |
It impacts cancer treatment. |
The molecule is a modulate and belongs to the cb1 antagonist class of molecules. |
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts tangier disease, diabetic heart disease, and aging. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, apoptosis that impacts non-alcoholic fatty liver disease and barth syndrome. |
The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, proton trap for oxidative phosphorylation, cholesterol translocation that impacts aging. The molecule is a apoptosis that impacts tangier disease, non-alcoholic fatty liver disease, diabetic heart disease, and barth syndrome. |
When heated to decomposition it emits toxic vapros of hydrogen chloride. |
The molecule is a tachykinin antagonist. |
The molecule is a glycogen phosphorylase inhibitor and belongs to the metabolic disorder treatment class of molecules, impacting diabetes treatment. |
The molecule is a nutrient that impacts both metabolic syndrome and atherosclerosis. The molecule is a fat storage and a thyroxine treatment, impacting both cardiovascular disease and pancreatitis. |
The molecule is a apoptosis and a cholesterol translocation that impacts tangier disease, barth syndrome, and non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts aging and diabetic heart disease. |
The molecule is a energy source that impacts diabetes mellitus type 2, breast cancer, and cardiovascular disease. It impacts celiac disease, heart failure, renal cell carcinoma, and inflammatory bowel disease. |
It has an effect on stomach cancer, and impacts diabetes mellitus, breast cancer, and parkinson's disease. It has an effect on colorectal cancer, and impacts alzheimer's disease, cardiovascular disease, and seizure. |
The molecule is a nutrient that affects both cervical cancer and breast cancer, and also impacts ulcerative colitis and atherosclerosis. |
The molecule is a apoptosis and a cholesterol translocation that impacts barth syndrome, aging, and tangier disease. The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts diabetic heart disease and non-alcoholic fatty liver disease. |
The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, apoptosis that impacts tangier disease and barth syndrome. The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, diabetic heart disease, and aging. |
The molecule is a inflammatory treatment member of the anti inflammatory class. |
The molecule is a nutrient. |
The molecule is a anti biotic and belongs to the anti microbial class of molecules, with the characteristic of being anti bacterial. |
The molecule is a nutrient that affects cervical cancer by impacting atherosclerosis, ulcerative colitis, and breast cancer. |
The molecule is a liquid crystal. |
The molecule is a nutrient. |
It belongs to the chemokine receptor modulator class of molecules. |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, apoptosis that impacts diabetic heart disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, and aging. |
The molecule is a diabetes treatment. |
The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts aging, barth syndrome, and tangier disease. The molecule is a stabilizing cytochrome oxidase, stabilizing mitochondrial structure, cholesterol translocation that impacts non-alcoholic fatty liver disease and diabetic heart disease. |
The molecule is a nutrient. |
The molecule is a nutrient, energy storage, thyroxine treatment that impacts obesity, cardiovascular disease, and atherosclerosis. The molecule is a inflammatory and energy source, and it impacts pancreatitis. The molecule is a fat storage and a membrane stabilizer, impacting both cancer and metabolic syndrome. |
The molecule is a cholesterol translocation, stabilizing mitochondrial structure, apoptosis, stabilizing cytochrome oxidase that impacts diabetic heart disease. The molecule is a proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease, aging, tangier disease, and barth syndrome. |
The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts barth syndrome, non-alcoholic fatty liver disease, and aging. The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts diabetic heart disease and tangier disease. |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation that impacts tangier disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts non-alcoholic fatty liver disease, aging, and barth syndrome. |
The molecule is a cholesterol translocation that impacts aging, diabetic heart disease, non-alcoholic fatty liver disease, and barth syndrome. The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts tangier disease. |
The molecule is a cholesterol translocation and a apoptosis that impacts non-alcoholic fatty liver disease, aging, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts tangier disease and barth syndrome. |
The molecule is a stabilizing mitochondrial structure and a cholesterol translocation that impacts barth syndrome, aging, and non-alcoholic fatty liver disease. The molecule is a apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts diabetic heart disease and tangier disease. |
The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, tangier disease, and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase, apoptosis, proton trap for oxidative phosphorylation that impacts aging and barth syndrome. |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase, apoptosis that impacts non-alcoholic fatty liver disease. The molecule is a proton trap for oxidative phosphorylation that impacts barth syndrome, tangier disease, diabetic heart disease, and aging. |
The molecule is a membrane stabilizer, energy source, and emulsifier that has an effect on prostate cancer and impacts both colorectal cancer and cardiovascular disease. The molecule is a surfactant that affects testicular cancer by impacting atherosclerosis. The molecule is a hormone, a signalling molecule, and a energy storage, and it impacts breast cancer. |
The molecule is odorless. |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, stabilizing cytochrome oxidase that impacts tangier disease and aging. The molecule is a apoptosis and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, barth syndrome, and non-alcoholic fatty liver disease. |
The molecule is a proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase, stabilizing mitochondrial structure that impacts tangier disease and diabetic heart disease. The molecule is a cholesterol translocation and a apoptosis that impacts barth syndrome, non-alcoholic fatty liver disease, and aging. |
The molecule is a energy source, surfactant, emulsifier, membrane stabilizer, nutrient, energy storage. |
The molecule is a inflammatory, energy source, membrane stabilizer, energy storage that impacts pancreatitis and metabolic syndrome. It has an effect on cancer, impacting both obesity and cardiovascular disease. The molecule is a nutrient and a fat storage, it impacts atherosclerosis, and is thyroxine treatment. |
The molecule is a nutrient that impacts both pancreatitis and cardiovascular disease. The molecule is a fat storage that impacts metabolic syndrome, atherosclerosis, and thyroxine treatment. |
The molecule is a member of the thyroxine treatment class and affects both pancreatitis and metabolic syndrome. The molecule is a nutrient and a fat storage, impacting both atherosclerosis and cardiovascular disease. |
The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts aging, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a apoptosis, stabilizing cytochrome oxidase, proton trap for oxidative phosphorylation that impacts tangier disease and barth syndrome. |
The molecule is a anti cancer member of the cancer treatment class. |
The molecule is a fat storage, a inflammatory, and a membrane stabilizer that impacts both cardiovascular disease and atherosclerosis, and is thyroxine treatment. The molecule is a energy storage that impacts both pancreatitis and obesity. The molecule is a energy source and a nutrient, with effects on cancer and impacts on metabolic syndrome. |
The molecule is a nutrient, fat storage, energy source that impacts metabolic syndrome, cancer, and obesity. The molecule is a inflammatory and membrane stabilizer, and it impacts cardiovascular disease. The molecule is a energy storage and a thyroxine treatment, impacting both atherosclerosis and pancreatitis. |
The molecule is a apoptosis, cholesterol translocation, stabilizing mitochondrial structure that impacts tangier disease and non-alcoholic fatty liver disease. The molecule is a stabilizing cytochrome oxidase and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, aging, and barth syndrome. |
The molecule is a fat storage and nutrient, and it impacts cardiovascular disease. The molecule is thyroxine treatment and impacts atherosclerosis, pancreatitis, and metabolic syndrome. |
The molecule is a proton trap for oxidative phosphorylation and a stabilizing mitochondrial structure that impacts barth syndrome, tangier disease, and aging. The molecule is a cholesterol translocation, stabilizing cytochrome oxidase, apoptosis that impacts non-alcoholic fatty liver disease and diabetic heart disease. |
The molecule is cancer treatment. |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, apoptosis, proton trap for oxidative phosphorylation that impacts barth syndrome. The molecule is a stabilizing cytochrome oxidase that impacts aging, tangier disease, non-alcoholic fatty liver disease, and diabetic heart disease. |
The molecule is a diabetes treatment member of the obesity treatment class. |
The molecule is a anti oxidant and belongs to both the anti viral and anti microbial classes of molecules. |
The molecule is a stabilizing cytochrome oxidase, a energy storage, and a food additive, and it impacts non-alcoholic fatty liver disease. The molecule is a surfactant, membrane stabilizer, stabilizing mitochondrial structure, nutritional supplement that impacts barth syndrome. The molecule is a proton trap for oxidative phosphorylation, a cholesterol translocation, a emulsifier, and smooth. The molecule is a apoptosis and a energy source that impacts diabetic heart disease, tangier disease, and aging. |
The molecule is a cholesterol translocation and a proton trap for oxidative phosphorylation that impacts diabetic heart disease, aging, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, stabilizing cytochrome oxidase, apoptosis that impacts barth syndrome and tangier disease. |
The molecule is a apoptosis and a stabilizing mitochondrial structure that impacts diabetic heart disease, barth syndrome, and tangier disease. The molecule is a stabilizing cytochrome oxidase, cholesterol translocation, proton trap for oxidative phosphorylation that impacts non-alcoholic fatty liver disease and aging. |
The molecule is a inflammatory, fat storage, energy source that impacts metabolic syndrome, atherosclerosis, and cardiovascular disease. The molecule is a nutrient that affects cancer by impacting obesity. The molecule is a membrane stabilizer, a thyroxine treatment, and a energy storage, and it impacts pancreatitis. |
The molecule is a anti tumour member of the cancer treatment class. |
The molecule is both a cgrp antagonist and a migraine treatment. |
The molecule is a proton trap for oxidative phosphorylation, apoptosis, stabilizing mitochondrial structure that impacts aging and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a cholesterol translocation that impacts barth syndrome, tangier disease, and non-alcoholic fatty liver disease. |
The molecule is a cholesterol translocation and a stabilizing cytochrome oxidase that impacts non-alcoholic fatty liver disease, barth syndrome, and tangier disease. The molecule is a stabilizing mitochondrial structure, apoptosis, proton trap for oxidative phosphorylation that impacts diabetic heart disease and aging. |
The molecule is a nutrient that affects both cervical cancer and breast cancer, and also impacts ulcerative colitis and atherosclerosis. |
The molecule is a apoptosis, cholesterol translocation, proton trap for oxidative phosphorylation that impacts tangier disease and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease, aging, and barth syndrome. |
The molecule is a energy source, inflammatory, energy storage that impacts obesity, cardiovascular disease, and cancer. The molecule is a nutrient and membrane stabilizer, and it impacts pancreatitis. The molecule is a fat storage that impacts atherosclerosis, metabolic syndrome, and thyroxine treatment. |
The molecule is a apoptosis, proton trap for oxidative phosphorylation, stabilizing cytochrome oxidase that impacts aging and barth syndrome. The molecule is a cholesterol translocation and a stabilizing mitochondrial structure that impacts tangier disease, non-alcoholic fatty liver disease, and diabetic heart disease. |
The molecule is a cholesterol translocation, proton trap for oxidative phosphorylation, stabilizing mitochondrial structure that impacts non-alcoholic fatty liver disease and diabetic heart disease. The molecule is a apoptosis and a stabilizing cytochrome oxidase that impacts aging, barth syndrome, and tangier disease. |
The molecule is a anti viral, ns5a inhibitor, hcv inhibitor, hepatitis c treatment. |
The molecule is a nutrient. |
The molecule is a proton trap for oxidative phosphorylation and a cholesterol translocation that impacts aging, diabetic heart disease, and tangier disease. The molecule is a stabilizing cytochrome oxidase, apoptosis, stabilizing mitochondrial structure that impacts barth syndrome and non-alcoholic fatty liver disease. |
The molecule is a energy storage, nutrient, surfactant, green, and fruity. The molecule is a energy source, emulsifier, membrane stabilizer, flavoring agent, and grape. |
The molecule is a potassium channel inhibitor. |
The molecule is a stabilizing mitochondrial structure, cholesterol translocation, proton trap for oxidative phosphorylation that impacts aging and diabetic heart disease. The molecule is a stabilizing cytochrome oxidase and a apoptosis that impacts tangier disease, non-alcoholic fatty liver disease, and barth syndrome. |
The molecule is a nutrient that affects breast cancer by impacting cervical cancer, ulcerative colitis, and atherosclerosis. |
The molecule is both a cancer treatment and a kinase inhibitor. |
The molecule is a stabilizing cytochrome oxidase that impacts barth syndrome, tangier disease, diabetic heart disease, and non-alcoholic fatty liver disease. The molecule is a stabilizing mitochondrial structure, apoptosis, proton trap for oxidative phosphorylation, cholesterol translocation that impacts aging. |
It impacts prostate cancer treatment. |
The molecule is a fat storage and energy source, belonging to the thyroxine treatment class of molecules, with effects on cancer and impacts on both metabolic syndrome and obesity. The molecule is a membrane stabilizer that impacts both pancreatitis and atherosclerosis. The molecule is a energy storage, a inflammatory, and a nutrient, and it impacts cardiovascular disease. |
The molecule is a thyroxine treatment that impacts both cardiovascular disease and pancreatitis. The molecule is a fat storage and a nutrient, impacting both atherosclerosis and metabolic syndrome. |
It impacts cancer treatment. |